Delivery Order 75N92023D00016-75N92024F00001
Award Date
9/23/24
Potential Completion Date
9/22/26
Potential Value
$7M
Federal Agency
National Heart Lung and Blood Institute
Awardee
New York Genome Center, Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
B599 - Special Studies/Analysis- Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10013, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $3,695,082 delivery order contract awarded by the National Heart, Lung and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC) for the NHLBI Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) program. The contract has a completion date of September 22, 2026 and uses a firm fixed price pricing model. NYGC is a non-profit organization that specializes in advanced genomic sequencing, analysis, and computational services for federal agencies....
This is a delivery order award to the New York Genome Center, Inc. (doing business as Nygc), a nonprofit academic research institution, under the Centralized Omic REsource for TOPMed (CORE) Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Heart, Lung, and Blood Institute (NHLBI). The order, valued at $5,906,039.00, is for the fifth year of the Centralized Omics Resource (CORE) project, which provides centralized omics data analysis and management services to support...
This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI) to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract, awarded under the NHLBI's Trans-Omics for Precision Medicine (TOPMed) program, is for NYGC to provide centralized omics data analysis and management services to support precision medicine research. The contract has a ceiling value of $742,360.00 and a performance period ending on September 27, 2026. The...
This is a $13,468,050.00 definitive, firm-fixed-price contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to the New York Genome Center, Inc. (NYGC), a nonprofit academic research institution. The contract is for special studies and analysis services, with no set-aside designation. NYGC has a $500 million indefinite delivery, indefinite quantity (IDIQ) contract with NHLBI for the Trans-Omics for Precision Medicine (TOPMed) program to provide...
This is a delivery order contract awarded by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health, to The Broad Institute, Inc. The contract is for the Centralized Omics Resource (CORE) program, which supports the Trans-Omics for Precision Medicine (TOPMed) initiative. The contract has a ceiling value of $36,386,600.12 and runs through September 27, 2026. The Broad Institute, a non-profit research organization affiliated with MIT and Harvard,...
This is a $24,910,368.70 firm fixed-price delivery order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to The Broad Institute, Inc., a non-profit research organization. The contract is for task areas 2, 3, and 4 of the NHLBI's Trans-Omics for Precision Medicine (TOPMed) Centralized Omics Resource (CORE) initiative, which supports large-scale genomics research. The contract has an ultimate completion date of...
This federal contract award, valued at $2,343,147.64, was issued by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The purpose of this modification is to add previously de-obligated funds of $674,819.76 to the existing Delivery Order. The contract, titled "Centralized Omics Resource (CORE)", is part of a larger Indefinite Delivery Contract between The Broad Institute and NHLBI, with a potential value of $500...
The National Institutes of Health National Heart, Lung and Blood Institute awarded a $22.4 million firm fixed price delivery order to The Broad Institute, Inc. under the Centralized Omic REsource for TOPMed (CORE) multiple award IDIQ. The Broad Institute will provide sequencing services to support the Trans-Omics for Precision Medicine program. As a non-profit research organization partnering with universities and medical centers, The Broad Institute leverages over $500 million in federal...
This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization, under the Centralized Omic REsource for TOPMed (CORE) contract. The contract has a ceiling value of $8,473,939.55 and supports the Centralized Omics Resource (CORE) program. The award does not have a set-aside designation. The Broad Institute will provide genomic sequencing, data analysis, computational biology, and translational research...
This is a $37,876,167 Firm Fixed Price definitive contract awarded by the National Heart Lung and Blood Institute (NHLBI) to The Broad Institute, Inc., a non-profit research organization. The contract supports the Trans-Omics for Precision Medicine (TOPMed) initiative through genomics data generation, analysis, and management services. This is an indefinite delivery contract with a 10-year, $500 million ceiling. The Broad Institute was also awarded a multiple-award Indefinite Delivery Indefinite...